SCARB1 and B-cell chronic lymphocytic leukemia: A similar study in CLL [34] determined that expression of SR-B1 on CLL cells, but not healthy B-cells, correlated with the cytotoxic effects of the nanoparticles towards the leukemic cells, but not their healthy counterpart.